Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

Abstract

Objective To study the validity of response criteria for rheumatoid arthritis (RA) that included 28‐joint counts instead of more comprehensive joint counts. Methods In a double‐blind, placebo‐controlled trial of 105 patients treated with methotrexate, sulfasalazine, or both, response was evaluated at week 52. Both European League Against Rheumatism and American College of Rheumatology definitions of response, with comprehensive as well as simplified joint counts, were calculated. We studied the differences between the criteria with and without simplified joint counts, the discriminating capacity between treatment groups, and the association with change in functional capacity and joint damage. Results Response criteria that included 28‐joint counts classified patients' responses more conservatively. No differences between treatment groups were found with either set of response criteria. The association with change in functional capacity was significant in all cases. All response criteria were significantly associated with radiographic progression of RA. Conclusion Improvement criteria that include 28‐joint counts are as valid as the original improvement criteria that included more comprehensive joint counts.

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial

“…Remission was defined according to the DAS28 remission criterion, DAS28<2.631 and good response according to the European League Against Rheumatism (EULAR) response criteria as improvement in DAS28 of at least 1.2 units and achievement of an absolute score of <3.2 33…”

Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients

“…We determined the responder status by the reduction in DAS28 after 16 weeks of therapy. RA patients with a reduction of the DAS28 of at least 1.2 (twice the measurement error of the DAS28 over time) were defined as responders, representing a clinically significant improvement 7. Patients not reaching this threshold were defined as non-responders.…”

Thinning of Choroidal Thickness in Patients with Rheumatoid Arthritis Unrelated to Disease Activity

“…The active group was further divided into 3 subgroups as follows: mild (2.65DAS-28 3.2), moderate (3.25DAS-28 5.1), and severe (DAS-2845.1). 23 …”